Advertisement
Screener

MANNKIND CORP (MNKD) Share-based Payment Arrangement, Expense

2.8 / 5 stars · 68/120 Roast Me

MANNKIND CORP Share-based Payment Arrangement, Expense

MANNKIND CORP (MNKD) reported Share-based Payment Arrangement, Expense of $10.23 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-05

  • MANNKIND CORP share-based payment arrangement, expense for the quarter ending 2026-06-30 was $10.23M, a 35.98% increase year-over-year.
  • MANNKIND CORP share-based payment arrangement, expense for the quarter ending 2026-03-31 was $6.46M, a 19.87% increase year-over-year.
  • MANNKIND CORP share-based payment arrangement, expense for the quarter ending 2025-12-31 was $6.97M, a 19.83% increase year-over-year.
  • MANNKIND CORP share-based payment arrangement, expense for the quarter ending 2025-09-30 was $4.32M, a 17.39% decline year-over-year.
  • MANNKIND CORP share-based payment arrangement, expense for fiscal 2025 was $24.20M, a 13.28% increase from fiscal 2024.
  • MANNKIND CORP share-based payment arrangement, expense for fiscal 2024 was $21.36M, a 21.02% increase from fiscal 2023.
  • MANNKIND CORP share-based payment arrangement, expense for fiscal 2023 was $17.65M, a 31.25% increase from fiscal 2022.
  • MANNKIND CORP share-based payment arrangement, expense for fiscal 2022 was $13.45M, a 10.22% increase from fiscal 2021.
Period endShare-based Payment Arrangement, Expense 1 monthShare-based Payment Arrangement, Expense 3 monthShare-based Payment Arrangement, Expense 3 month as first filedShare-based Payment Arrangement, Expense 6 monthShare-based Payment Arrangement, Expense 9 monthShare-based Payment Arrangement, Expense 12 month
2026-06-30$10.23M
10-Q · filed 2026-08-05
$16.68M
10-Q · filed 2026-08-05
$23.65M
derived: sum of 3 quarters · filed 2026-08-05
$27.97M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31$6.46M
10-Q · filed 2026-05-06
$13.43M
derived: sum of 2 quarters · filed 2026-05-06
$17.75M
derived: sum of 3 quarters · filed 2026-05-06
$25.27M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31$6.97M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$11.29M
derived: sum of 2 quarters · filed 2026-02-26
$18.81M
derived: sum of 3 quarters · filed 2026-08-05
$24.20M
10-K · filed 2026-02-26
2025-09-30$4.32M
10-Q · filed 2025-11-05
$11.84M
derived: sum of 2 quarters · filed 2026-08-05
$17.22M
10-Q · filed 2025-11-05
$23.04M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$7.52M
10-Q · filed 2026-08-05
$12.90M
10-Q · filed 2026-08-05
$18.72M
derived: sum of 3 quarters · filed 2026-08-05
$23.95M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31$5.38M
10-Q · filed 2026-05-06
$11.20M
derived: sum of 2 quarters · filed 2026-05-06
$16.43M
derived: sum of 3 quarters · filed 2026-05-06
$22.86M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$5.82M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$11.04M
derived: sum of 2 quarters · filed 2026-02-26
$17.47M
derived: sum of 3 quarters · filed 2026-02-26
$21.36M
10-K · filed 2026-02-26
2024-09-30$5.23M
10-Q · filed 2025-11-05
$11.65M
derived: sum of 2 quarters · filed 2025-11-05
$15.54M
10-Q · filed 2025-11-05
$19.35M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$6.43M
10-Q · filed 2025-08-06
$10.31M
10-Q · filed 2025-08-06
$14.13M
derived: sum of 3 quarters · filed 2026-02-26
$18.73M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$3.88M
10-Q · filed 2025-05-08
$7.70M
derived: sum of 2 quarters · filed 2026-02-26
$12.30M
derived: sum of 3 quarters · filed 2026-02-26
$17.88M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$3.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$8.41M
derived: sum of 2 quarters · filed 2026-02-26
$13.99M
derived: sum of 3 quarters · filed 2026-02-26
$17.65M
10-K · filed 2026-02-26
2023-09-30$4.60M
10-Q · filed 2024-11-07
$10.18M
derived: sum of 2 quarters · filed 2024-11-07
$13.84M
10-Q · filed 2024-11-07
$16.43M
derived: sum of 4 quarters · filed 2025-02-26
2023-06-30$5.58M
10-Q · filed 2024-08-07
$9.23M
10-Q · filed 2024-08-07
$11.83M
derived: sum of 3 quarters · filed 2025-02-26
$15.45M
derived: sum of 4 quarters · filed 2025-02-26
2023-03-31$3.65M
10-Q · filed 2024-05-08
$6.25M
derived: sum of 2 quarters · filed 2025-02-26
$9.87M
derived: sum of 3 quarters · filed 2025-02-26
$14.30M
derived: sum of 4 quarters · filed 2025-02-26
2022-12-31$2.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26
$6.22M
derived: sum of 2 quarters · filed 2025-02-26
$10.64M
derived: sum of 3 quarters · filed 2025-02-26
$13.45M
10-K · filed 2025-02-26
2022-09-30$3.62M
10-Q · filed 2023-11-07
$8.04M
derived: sum of 2 quarters · filed 2023-11-07
$10.85M
10-Q · filed 2023-11-07
$14.01M
derived: sum of 4 quarters · filed 2024-02-27
2022-06-30$4.42M
10-Q · filed 2023-08-07
$7.23M
10-Q · filed 2023-08-07
$10.39M
derived: sum of 3 quarters · filed 2024-02-27
$13.57M
derived: sum of 4 quarters · filed 2024-02-27
2022-03-31$2.81M
10-Q · filed 2023-05-09
$5.97M
derived: sum of 2 quarters · filed 2024-02-27
$9.14M
derived: sum of 3 quarters · filed 2024-02-27
$13.07M
derived: sum of 4 quarters · filed 2024-02-27
2021-12-31$3.16M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27
$6.34M
derived: sum of 2 quarters · filed 2024-02-27
$10.27M
derived: sum of 3 quarters · filed 2024-02-27
$12.20M
10-K · filed 2024-02-27
2021-09-30$3.18M
10-Q · filed 2022-11-08
$7.11M
derived: sum of 2 quarters · filed 2022-11-08
$9.04M
10-Q · filed 2022-11-08
$10.94M
derived: sum of 4 quarters · filed 2023-02-23
2021-06-30$3.93M
10-Q · filed 2022-08-09
$5.86M
10-Q · filed 2022-08-09
$7.76M
derived: sum of 3 quarters · filed 2023-02-23
$9.06M
derived: sum of 4 quarters · filed 2023-02-23
2021-03-31$1.94M
10-Q · filed 2022-05-05
$3.84M
derived: sum of 2 quarters · filed 2023-02-23
$5.13M
derived: sum of 3 quarters · filed 2023-02-23
$7.32M
derived: sum of 4 quarters · filed 2023-02-23
2020-12-31$1.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
$3.20M
derived: sum of 2 quarters · filed 2023-02-23
$5.38M
derived: sum of 3 quarters · filed 2023-02-23
$6.51M
10-K · filed 2023-02-23
2020-09-30$1.29M
10-Q · filed 2021-11-09
$3.48M
derived: sum of 2 quarters · filed 2021-11-09
$4.61M
10-Q · filed 2021-11-09
$5.50M
derived: sum of 4 quarters · filed 2021-11-09
2020-06-30$2.19M
10-Q · filed 2021-08-11
$3.31M
10-Q · filed 2021-08-11
$4.20M
derived: sum of 3 quarters · filed 2021-08-11
$5.84M
derived: sum of 4 quarters · filed 2021-08-11
2020-03-31$1.13M
10-Q · filed 2021-05-12
$2.02M
derived: sum of 2 quarters · filed 2021-05-12
$3.66M
derived: sum of 3 quarters · filed 2021-05-12
$6.23M
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31$891.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$2.53M
derived: sum of 2 quarters · filed 2021-02-25
$5.10M
derived: sum of 3 quarters · filed 2021-02-25
$6.20M
10-K · filed 2021-02-25
2019-09-30$1.64M
10-Q · filed 2020-11-04
$4.21M
derived: sum of 2 quarters · filed 2020-11-04
$5.31M
10-Q · filed 2020-11-04
$6.35M
derived: sum of 4 quarters · filed 2020-11-04
2019-06-30$2.57M
10-Q · filed 2020-08-05
$3.67M
10-Q · filed 2020-08-05
$4.71M
derived: sum of 3 quarters · filed 2020-08-05
$6.27M
derived: sum of 4 quarters · filed 2020-08-05
2019-03-31$999.00K
10-Q · filed 2020-05-06
$2.14M
derived: sum of 2 quarters · filed 2020-05-06
$3.70M
derived: sum of 3 quarters · filed 2020-05-06
$5.91M
derived: sum of 4 quarters · filed 2020-05-06
2018-12-31$1.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$2.70M
derived: sum of 2 quarters · filed 2020-02-25
$4.91M
derived: sum of 3 quarters · filed 2020-02-25
$6.86M
10-K · filed 2020-02-25
2018-09-30$1.56M
10-Q · filed 2019-11-08
$3.77M
derived: sum of 2 quarters · filed 2019-11-08
$5.71M
10-Q · filed 2019-11-08
$6.80M
derived: sum of 4 quarters · filed 2019-11-08
2018-06-30$2.21M
10-Q · filed 2019-08-07
$4.15M
10-Q · filed 2019-08-07
$5.24M
derived: sum of 3 quarters · filed 2019-08-07
$6.48M
derived: sum of 4 quarters · filed 2019-08-07
2018-03-31$1.94M
10-Q · filed 2019-05-07
$3.03M
derived: sum of 2 quarters · filed 2019-05-07
$4.27M
derived: sum of 3 quarters · filed 2019-05-07
$5.52M
derived: sum of 4 quarters · filed 2019-05-07
2017-12-31$1.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
$2.33M
derived: sum of 2 quarters · filed 2019-02-26
$3.58M
derived: sum of 3 quarters · filed 2019-02-26
$4.85M
10-K · filed 2019-02-26
2017-09-30$1.25M
10-Q · filed 2018-11-01
$2.50M
derived: sum of 2 quarters · filed 2018-11-01
$3.76M
10-Q · filed 2018-11-01
$4.77M
derived: sum of 4 quarters · filed 2019-02-26
2017-06-30$1.25M
10-Q · filed 2018-08-02
$2.52M
10-Q · filed 2018-08-02
$3.52M
derived: sum of 3 quarters · filed 2019-02-26
$5.02M
derived: sum of 4 quarters · filed 2019-02-26
2017-03-31$1.27M
10-Q · filed 2018-05-09
$1.30M
10-Q · filed 2017-05-10
$2.27M
derived: sum of 2 quarters · filed 2019-02-26
$3.77M
derived: sum of 3 quarters · filed 2019-02-26
$5.13M
derived: sum of 4 quarters · filed 2019-02-26
2016-12-31$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
$2.51M
derived: sum of 2 quarters · filed 2019-02-26
$3.86M
derived: sum of 3 quarters · filed 2019-02-26
$5.13M
10-K · filed 2019-02-26
2016-09-30$1.50M
10-Q · filed 2017-11-07
$2.86M
derived: sum of 2 quarters · filed 2017-11-07
$4.13M
10-Q · filed 2017-11-07
$6.50M
derived: sum of 4 quarters · filed 2018-02-27
2016-06-30$1.35M
10-Q · filed 2017-08-07
$2.63M
10-Q · filed 2017-08-07
$5.00M
derived: sum of 3 quarters · filed 2018-02-27
$7.60M
derived: sum of 4 quarters · filed 2018-02-27
2016-03-31$1.30M
10-Q · filed 2017-05-10
$1.27M
10-Q · filed 2016-05-09
$3.65M
derived: sum of 2 quarters · filed 2018-02-27
$6.25M
derived: sum of 3 quarters · filed 2018-02-27
$8.02M
derived: sum of 4 quarters · filed 2018-02-27
2015-12-31$2.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
$4.95M
derived: sum of 2 quarters · filed 2018-02-27
$6.72M
derived: sum of 3 quarters · filed 2018-02-27
$8.72M
10-K · filed 2018-02-27
2015-09-30$2.60M
10-Q · filed 2016-11-09
$4.38M
derived: sum of 2 quarters · filed 2016-11-09
$6.38M
10-Q · filed 2016-11-09
$8.24M
derived: sum of 4 quarters · filed 2017-03-16
2015-06-30$1.77M
10-Q/A · filed 2016-08-10
$3.78M
10-Q/A · filed 2016-08-10
$5.64M
derived: sum of 3 quarters · filed 2017-03-16
$818.00K
derived: sum of 4 quarters · filed 2017-03-16
2015-03-31$2.00M
10-Q · filed 2016-05-09
$2.00M
10-Q · filed 2015-05-11
$3.87M
derived: sum of 2 quarters · filed 2017-03-16
-$957.00K
derived: sum of 3 quarters · filed 2017-03-16
$39.69M
derived: sum of 4 quarters · filed 2017-03-16
2014-12-31$1.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16
-$2.96M
derived: sum of 2 quarters · filed 2017-03-16
$37.68M
derived: sum of 3 quarters · filed 2017-03-16
$48.62M
10-K · filed 2017-03-16
2014-09-30-$4.83M
10-Q · filed 2015-11-09
$35.82M
derived: sum of 2 quarters · filed 2015-11-09
$46.76M
10-Q · filed 2015-11-09
$54.90M
derived: sum of 4 quarters · filed 2016-03-15
2014-06-30$40.64M
10-Q · filed 2015-08-10
$51.58M
10-Q · filed 2015-08-10
$59.73M
derived: sum of 3 quarters · filed 2016-03-15
$75.67M
derived: sum of 4 quarters · filed 2016-03-15
2014-03-31$5.20M
10-Q · filed 2015-05-11
$10.94M
10-Q · filed 2014-05-12
$19.08M
derived: sum of 2 quarters · filed 2016-03-15
$35.02M
derived: sum of 3 quarters · filed 2016-03-15
$45.20M
derived: sum of 4 quarters · filed 2016-03-15
2013-12-31$13.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15
$29.82M
derived: sum of 2 quarters · filed 2016-03-15
$40.00M
derived: sum of 3 quarters · filed 2016-03-15
$45.19M
10-K · filed 2016-03-15
2013-09-30$15.94M
10-Q · filed 2014-11-10
$26.11M
derived: sum of 2 quarters · filed 2014-11-10
$31.30M
10-Q · filed 2014-11-10
$34.83M
derived: sum of 4 quarters · filed 2015-03-02
2013-06-30$10.17M
10-Q · filed 2014-08-11
$15.36M
10-Q · filed 2014-08-11
$18.88M
derived: sum of 3 quarters · filed 2015-03-02
$22.70M
derived: sum of 4 quarters · filed 2015-03-02
2013-03-31$5.19M
10-Q · filed 2014-05-12
$8.71M
derived: sum of 2 quarters · filed 2015-03-02
$12.53M
derived: sum of 3 quarters · filed 2015-03-02
$15.60M
derived: sum of 4 quarters · filed 2015-03-02
2012-12-31$3.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
$7.34M
derived: sum of 2 quarters · filed 2015-03-02
$10.41M
derived: sum of 3 quarters · filed 2015-03-02
$13.29M
10-K · filed 2015-03-02
2012-09-30$3.82M
10-Q · filed 2013-11-12
$6.89M
derived: sum of 2 quarters · filed 2013-11-12
$9.77M
10-Q · filed 2013-11-12
$12.95M
derived: sum of 4 quarters · filed 2014-03-03
2012-06-30$3.07M
10-Q · filed 2013-08-09
$5.95M
10-Q · filed 2013-08-09
$9.13M
derived: sum of 3 quarters · filed 2014-03-03
$12.45M
derived: sum of 4 quarters · filed 2014-03-03
2012-03-31$2.88M
10-Q · filed 2013-05-10
$6.06M
derived: sum of 2 quarters · filed 2014-03-03
$9.38M
derived: sum of 3 quarters · filed 2014-03-03
$11.37M
derived: sum of 4 quarters · filed 2014-03-03
2011-12-31$3.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03
$6.50M
derived: sum of 2 quarters · filed 2014-03-03
$8.49M
derived: sum of 3 quarters · filed 2014-03-03
$11.20M
10-K · filed 2014-03-03
2011-09-30$3.32M
10-Q · filed 2012-11-09
$5.31M
derived: sum of 2 quarters · filed 2012-11-09
$8.02M
10-Q · filed 2012-11-09
2011-06-30$1.99M
10-Q · filed 2012-08-09
$4.70M
10-Q · filed 2012-08-09
2011-03-03$8.20M
10-K · filed 2013-03-18
2010-12-31$13.58M
10-K · filed 2013-03-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
Savara Inc (SVRA)United States$1.044B-9.10
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
Amphastar Pharmaceuticals, Inc. (AMPH)United States$1.116B10.93
Corvus Pharmaceuticals, Inc. (CRVS)United States$0.994B-23.25
Seaport Therapeutics, Inc. (SPTX)United States$1.131B
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Arbutus Biopharma Corp (ABUS)$0.965B6.19